Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
REFERENCES Manifestations of fatigue that may occur when status or supplies of these micronutrients are not adequate. Consuming adequate intakes of vitamins and minerals contributes to maintenance of normal cognitive function and to enhanced well-being by decreasing perceived mental and physical fatigue and favoring positive mood
Falutz J, Allas S, Blot K, et al
Science, Benefits, and What Actually Works Discover whether oral peptides like MK-677 and BPC-157 support muscle growth, recovery, and longevity
Sleep disruptions from shoulder pain should decrease as BPC-157 takes effect, creating a positive feedback loop where better healing enables better sleep which supports more healing
US$ 28.98
US$ 22.84
US$ 20.47
US$ 23.99